Advances in bevacizumab in colorectal cancer: a bibliometric analysis from 2004 to 2023
{{output}}
Background: Bevacizumab is a primary focus in the clinical application and research of metastatic colorectal cancer (mCRC) patients. This study aims to analyze publications on bevacizumab and CRC to explore and identify the trend... ...
